From a mechanistic point of view, recent work from the literature also suggested that Aca eradicates CML cells by suppressing activation of the mTOR pathway in BCR-ABL expressing cells [22]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.